BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AnalytiXIN - ECPv6.17.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AnalytiXIN
X-ORIGINAL-URL:https://analytixindiana.com
X-WR-CALDESC:Events for AnalytiXIN
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Indiana/Indianapolis
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Indiana/Indianapolis:20260930T120000
DTEND;TZID=America/Indiana/Indianapolis:20260930T130000
DTSTAMP:20260818T133633Z
CREATED:20260817T181503Z
LAST-MODIFIED:20260818T133633Z
UID:10000052-1790769600-1790773200@analytixindiana.com
SUMMARY:AnalytiXIN Spotlight Series: Introducing Provena Consortium
DESCRIPTION:AnalytiXIN invites life sciences stakeholders across Indiana to a virtual Spotlight Series session introducing Provena Consortium\, the newly rebranded name for Indiana’s Life Sciences Health Data Asset. \nProvena Consortium is a consent-based clinical and genomic data consortium built through a partnership between Indiana University\, IU Health\, Eli Lilly and Company\, and the Indiana Health Information Exchange. With more than 90\,000 participants consented and a goal of reaching 250\,000 by early 2029\, Provena Consortium is positioning Indiana to host one of the largest deeply characterized\, consent-based health data assets in the country — combining whole-genome sequencing\, decades of longitudinal clinical depth\, and the ability to recontact participants for future research and clinical trial opportunities. \nSpeakers \n\nDarshan Shah\, EVP\, Data and AnalytiXIN\, CEOs of Indiana Corporate Partnership\nYunlong Liu\, PhD\, Professor of Medical and Molecular Genetics\, Indiana University School of Medicine\nBrooke Patz\, Senior Project Manager\, Indiana Biobank\nTim Ryan\, Vice President of Outcomes Research\, Diabetes\, Obesity\, and Complications Research\, Eli Lilly and Company\n\nDuring this session\, you’ll hear directly from the partners building Provena Consortium on: \n\nA live look at the research portal and how institutions and industry can engage with it\nHow Provena Consortium is already accelerating trial enrollment\, precision medicine\, and cross-institutional research\nWhat’s ahead as Provena Consortium scales toward its 2029 goals\n\nThis session is presented in partnership with BioCrossroads and is especially relevant for life sciences researchers\, industry partners\, and health system leaders across Indiana. \nRegister today to join the conversation.
URL:https://analytixindiana.com/default-event/analytixin-spotlight-series-introducing-provena-consortium/
ATTACH;FMTTYPE=image/jpeg:https://analytixindiana.com/wp-content/uploads/2024/10/ANI-Timeline-Image-1.jpg
END:VEVENT
END:VCALENDAR